{
    "2020-04-19": [
        [
            {
                "time": "",
                "original_text": "只个股被QFII“看中”，这些个股股价翻倍！4只医药股、3只交通运输股已被连续持有3年",
                "features": {
                    "keywords": [
                        "QFII",
                        "股价翻倍",
                        "医药股",
                        "交通运输股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "交通运输"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药拟A+H两地上市？港股IPO审查获受理",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "A+H两地上市",
                        "港股IPO",
                        "审查受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：发行H股申请材料获中国证监会受理",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "H股",
                        "证监会受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：发行境外上市外资股(H股)申请材料获中证监受理",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "H股",
                        "证监会受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}